Evidence status: CURRENT INSTITUTIONAL POLICY / REVISED JULY 30, 2026. Rutgers University Policy 100.2.11, Prescribing Controlled Substances (Opioids), is a current Rutgers Health compliance policy that incorporates New Jersey’s pain-management-agreement framework into institutional prescribing practice.

Current policy status

The Rutgers Policy Library identifies Policy 100.2.11 as a Healthcare Compliance Policy. It was adopted June 12, 2017 and was last reviewed and revised July 30, 2026.

How Rutgers defines the agreement

The policy defines a Pain Management Agreement, also called a Patient Provider Agreement, as a written agreement executed before chronic-pain opioid treatment. Its listed purposes track New Jersey law: preventing possible dependence, documenting the treatment plan, establishing patient rights and responsibilities, identifying medication and other treatment modes, specifying compliance monitoring such as random drug screens and pill counts, and defining agreement termination and consequences.

Rutgers-specific implementation

• Rutgers practitioners are directed to honor known current pain-management agreements between a patient and another provider.
• For long-term pain management, the policy directs practitioners to obtain a signed Pain Management Agreement and renew it annually.
• For subsequent opioid prescribing, the policy directs practitioners to ensure the agreement remains on file and up to date.
• For opioids prescribed three months or more for chronic pain, the policy requires recurring assessment, documented efforts to reduce exposure when appropriate, at least three-month review of treatment progress, consideration of specialist referral, and monitoring of agreement compliance.
• The policy links directly to the New Jersey state model agreement, Board rule, Board FAQ, Prescription Monitoring Program, and Rutgers’ opioid toolkit.

State law versus Rutgers policy

New Jersey requires the agreement before ongoing chronic-pain treatment, but Rutgers’ annual agreement-renewal practice is an institutional policy choice unless another binding authority independently imposes that annual renewal requirement.

Primary source

• Rutgers Policy 100.2.11 — Prescribing Controlled Substances (Opioids)

Reviewed: October 4, 2026.

Evidence boundary: Rutgers’ institutional policy can be stricter than the New Jersey regulatory floor. Institutional additions are identified separately from statewide mandates.